Recombinant Humanized (from mouse) antibody to Human ITGA4+ITGB7. It is a monoclonal antibody for the treatment of ulcerative colitis and Crohn's disease.It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name vedolizumab.
Figure 1 Anti-alpha 4 beta 7 Antibody (TAB-H75) in ELISA
ELISA analysis of TAB-H75 was performed by coating with Human alpha 4 beta 7 Protein.
Figure 2 Anti-alpha 4 beta 7 Antibody (TAB-H75) in Dot Blot
Dot Blot analysis of TAB-H75 was performed by coating with Human alpha 4 beta 7 Protein.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H02 | Anti-Human ITGA4+ITGB7 Recombinant Antibody (TAB-H02) | IP, IF, FuncS, FC, Neut, ELISA, WB | IgG2 - kappa |
There are currently no Customer reviews or questions for TAB-H75. Click the button above to contact us or submit your feedback about this product.
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-H75, RRID: AB_3112046)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.